Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities

Psoriatic arthritis (PsA) is a chronic inflammatory immune-mediated disease that affects approximately 30% of psoriasis patients. In most cases, skin disease clearly precedes the musculoskeletal disease. Some studies suggest that targeted treatment may intercept the disease course and prevent psoria...

Descripción completa

Detalles Bibliográficos
Autores principales: Koehm, Michaela, Behrens, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514622/
https://www.ncbi.nlm.nih.gov/pubmed/37734874
http://dx.doi.org/10.1136/rmdopen-2023-003166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514622/
https://www.ncbi.nlm.nih.gov/pubmed/37734874
http://dx.doi.org/10.1136/rmdopen-2023-003166

Ejemplares similares